Omega Diagnostics Group PLC
ODX.L · LSE
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Market Cap | £72 | £7,032 | £138,209 | £10,698 |
| - Cash | £5,115 | £1,605 | £5,827 | -£1,791 |
| + Debt | £74 | £370 | £2,842 | £2,573 |
| Enterprise Value | -£4,969 | £5,797 | £135,224 | £15,061 |
| Revenue | £7,546 | £8,539 | £8,735 | £9,819 |
| % Growth | -11.6% | -2.2% | -11% | – |
| Gross Profit | £3,545 | £5,102 | £4,459 | £6,294 |
| % Margin | 47% | 59.7% | 51% | 64.1% |
| EBITDA | -£2,648 | £360 | -£2,436 | -£6,894 |
| % Margin | -35.1% | 4.2% | -27.9% | -70.2% |
| Net Income | -£3,860 | -£1,409 | -£2,104 | -£6,828 |
| % Margin | -51.2% | -16.5% | -24.1% | -69.5% |
| EPS Diluted | -0.017 | -0.008 | -0.012 | -0.048 |
| % Growth | -121.3% | 37% | 75.3% | – |
| Operating Cash Flow | -£3,152 | -£3,229 | -£2,420 | £548 |
| Capital Expenditures | -£153 | -£1,478 | -£2,825 | -£2,154 |
| Free Cash Flow | -£3,305 | -£4,707 | -£5,244 | -£1,606 |